TheraSolve Receives Patent for MemoPatch

Medical technology and adherence company TheraSolve has received a patent from the United States Patent and Trademark Office for its MemoPatch reminder technology.

MemoPatch is a self-adhesive dermal patch that gives patients a stimulus on the skin when it is time to take a next dose of medication.

The objective of the patch is to help patients successfully adhere to their medication regimens over a longer period of time.

The device is patent protected in the U.S., EU, Japan, China and India. — Michael Cipriano